An interventional study of telenursing and reminders in COPD, sponsored by Çanakkale Onsekiz Mart University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2026-11-10.
Sponsored by Çanakkale Onsekiz Mart University · Not applicable, Interventional, and Supportive care
This research will be conducted using a pre-test and post-test control group experimental design to evaluate the effect of telenursing intervention on oral health in individuals with COPD.
Studies evaluating the effectiveness of oral health interventions in individuals with COPD are limited in the literature. Maintaining oral health is a crucial part of patient care. Sustainable nursing interventions are necessary from the onset of the disease to the end of life. Patient education conducted by nurses is important in improving medication adherence and preventing comorbidities. Furthermore, it is known that practices involving a multidisciplinary team approach with nurse participation reduce readmissions and hospital stays for COPD patients. Therefore, this study aims to evaluate the effect of telenursing intervention on oral health in individuals with COPD. The experimental group will receive oral health education via telenursing intervention (via video call) and daily oral health reminders. The control group will not receive education. Oral health education for the experimental group is planned to be given within 24 hours after the pre-test. The experimental group will be invited to the hospital one month after the oral health education for evaluation of oral health and quality of life related to oral health, and the control group will be invited one month after the pre-test.
5,520 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 856 are open to participants now.
This study's planned enrollment of 80 is above the median of 62 across 3,839 interventional studies indexed under Pulmonary Disease, Chronic Obstructive.
Browse Pulmonary Disease, Chronic Obstructive studies →Çanakkale Onsekiz Mart University is the lead sponsor of 51 studies on the registry; 15 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The experimental group will receive oral health education via telenursing intervention (via video call) and daily oral health reminders. Oral health education for the experimental group is planned to be given within 24 hours after the pre-test. Participants will also receive reminders regarding oral hygiene, including "performing oral care at least twice a day, every day" and "rinsing their mouths with water after using an inhaler." The experimental group will be invited to the hospital one month after the oral health education for evaluation of oral health and quality of life related to oral health.
Behavioral: telenursing · Behavioral: reminders
The control group will not receive training. They will be invited to the hospital for an oral health and quality of life check one month after the initial follow-up.
The responsible researcher will provide oral health education to the experimental group via video call during the telenursing intervention. The content of the education will include oral health in adults; the consequences of poor oral hygiene; things to pay attention to in oral health; demonstration of toothbrushing technique; and coping with care-resistant behaviors. Participants' questions regarding oral health will be answered during the call. The oral health education session is planned to last approximately 20 minutes.
Participants in the experimental group will be reminded to perform oral care at least twice a day, every day, and to rinse their mouths with water after using an inhaler. They will also be reminded to schedule a face-to-face meeting one month after the education.
oral healt
The Oral Assessment Guide (ADR) will be used to evaluate oral health. The guide supports the creation of an oral care protocol for patients with impaired oral mucosal membranes. Scores on the guide range from 8 to 24. According to the ADR, a low score indicates good oral health, while a high score indicates negative changes in oral health. The oral mucosal membrane score will be evaluated in both pre-test and post-test. A light source and a tongue depressor (one for each participant) are planned to be used during the oral health assessment.
Time frame: pre-test and post-test (1 month)
Quality of Life Related to Oral Health
The scale has seven sub-dimensions: 'Functional Limitation', 'Physical Pain', 'Psychological Distress', 'Physical Disability', 'Psychological Disability', 'Social Disability', and 'Handicap'. Scores obtainable from the Oral Health Impact Scale range from 0 to 56. Since all questions are in a negative form, a score close to 0 indicates good quality of life related to oral and dental health, while a score close to 56 indicates poor quality of life related to oral and dental health. A high score on the scale indicates low quality of life related to oral health.
Time frame: pre-test and post-test (1 month)
Plan to share: Yes — The datasets generated and/or analysed during the current study are not publicly available due privacy reasons but are available from the corresponding author on reasonable request.
No publications or documents are linked to this record.
Ran from Mar 2026 to primary completion in Mar 2026, 0 months.
Of 1,094 non-industry interventional studies with no phase under Pulmonary Disease, Chronic Obstructive, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's 0 months is below that.
Counting every sponsor, half of 1,181 studies reached it within 22 months; a quarter within 10 and three quarters within 39.
Completion moved once since we started tracking on Sep 25, 2026: Jun 2026 → Dec 2026, on Nov 10, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pulmonary Disease, Chronic Obstructive →
Çanakkale Onsekiz Mart University